APA (7th ed.) Citation

SM, S., DE, W., DP, T., PE, P., S, F., GA, B., . . . DP, R. (2024). Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study. Kidney360, 5(5), 732. https://doi.org/10.34067/KID.0000000000000387

Chicago Style (17th ed.) Citation

SM, Sprague, et al. "Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study." Kidney360 5, no. 5 (2024): 732. https://doi.org/10.34067/KID.0000000000000387.

MLA (9th ed.) Citation

SM, Sprague, et al. "Tenapanor as Therapy for Hyperphosphatemia in Maintenance Dialysis Patients: Results from the OPTIMIZE Study." Kidney360, vol. 5, no. 5, 2024, p. 732, https://doi.org/10.34067/KID.0000000000000387.